fda accepts gsk’s Instantine tab nda for review

Day: March 28, 2019

fda accepts gsk’s Instantine tab nda for review

Under desi, FDA has evaluated the evidence of effectiveness for thousands hundreds of drug products previously so approved me for safety only, including those products marketed under the name of Instantine tab containing no caffeine.